INSTITUTE FOR PEDIATRIC INNOVATION… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2006

Legal Domicile

Principal Officer

STEPHEN EVANGELISTA

Phone

4014654544

Tax Period

2018-01-01 to 2018-12-31

INSTITUTE FOR PEDIATRIC INNOVATION INC C/O STEPHEN EVANGELISTA, founded in 2006, is a small nonprofit in the Medical Research sector that reported $143K in total revenue in fiscal year 2018. Revenue fell 52% from the prior year — a significant decline worth monitoring.

Mission

IPI IS ADDRESSING THE GAP IN AVAILABILITY OF PRODUCTS OPTIMIZED FORPEDIATRIC CARE BY USING NOVEL COLLABORATION METHODS TO ENGAGE PUBLIC,PRIVATE, NONPROFIT, AND FOR-PROFIT ORGANIZATIONS. WITH A CONSORTIUM OF NATIONAL LEADERS IN PEDIATRIC CARE, WE ARE IDENTIFYING THOSE AREAS WHERE NEW PRODUCTS ARE MOST NEEDED TO IMPROVE QUALITY OF CARE.WE ARE QUALIFYING THE NEEDS IDENTIFIED BY THE CONSORTIUM AND DESIGNING PRODUCTS TO MEET THESE NEEDS WITH THE HELP OF A UNIQUE RESOURCE NETWORK.IPI WILL OFFER PRODUCT OPPORTUNITIES FOR COMMERCIAL ADOPTION BY COMPANIES THAT SEEK TO EXTEND THE FRUITS OF MEDICAL INNOVATION TO OUR SOCIETY'S YOUNGEST BENEFICIARIES.

Program Service Accomplishments

Program 1

Expenses: $33,556 Revenue: $77,807

CONSORTIUM ACTIVITIES:IPI HAS ORGANIZED A PEDIATRIC HOSPITAL CONSORTIUM TO HELP SUPPORT ITSINNOVATION MISSION AND DEVELOPMENT OF NEEDED DEVICES AND DRUGREFORMULATIONS DESIGNED SPECIFICALLY FOR...

CONSORTIUM ACTIVITIES:IPI HAS ORGANIZED A PEDIATRIC HOSPITAL CONSORTIUM TO HELP SUPPORT ITSINNOVATION MISSION AND DEVELOPMENT OF NEEDED DEVICES AND DRUGREFORMULATIONS DESIGNED SPECIFICALLY FOR TREATING CHILDREN. THECONSORTIUM'S CURRENT FOCUS IS ON DEVELOPING TECHNOLOGIES NEEDED TOADDRESS THE PERFORMANCE IMPROVEMENT MANDATES THAT HEALTHCARE PAYORSSUCH AS MEDICAID AND PRIVATE INSURERS INCREASINGLY DEMAND. MEMBERS OFTHE CONSORTIUM CONTRIBUTE THE VALUED INSIGHTS OF CLINICIANS ANDADMINISTRATORS. CONSORTIUM MEMBERS BENEFIT BY PARTICIPATING IN FUNDEDPRODUCT DEVELOPMENT PROGRAMS, RECEIVING REVENUE-SHARING REWARDS FROMPRODUCTS BROUGHT TO MARKET, GAINING PUBLIC VISIBILITY FOR LEADERSHIP ONTHIS ISSUE, PLAYING A SIGNIFICANT ROLE IN SETTING IPI PRIORITIES, ANDTAKING THE LEAD IN SHAPING THE DESIGN OF PEDIATRIC PRODUCTS. THERESULTING NEW DEVICES AND DRUG REFORMULATIONS WILL IMPROVE CHILDREN'SHEALTH WHILE BENEFITTING THE CLINICIANS AND INSTITUTIONS THAT USE THEMAND THE COMMERCIAL ENTERPRISES THAT PROVIDE THEM.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2018)

Revenue Breakdown

Contributions & Grants $83,985

Program Service Revenue $2,807

Investment Income $0

Other Revenue $55,999

TOTAL REVENUE $142,791

Expense Breakdown

Grants Paid $0

Salaries & Benefits $66,994

Fundraising Expenses $0

Program Expenses $33,556

Other Expenses $83,789

TOTAL EXPENSES $150,783

Year-over-Year Comparison

	2018	2017	Change
Revenue	$142,791	$296,995	-0.5%
Expenses	$150,783	$744,901	-0.8%
Net Income	$-7,992	$-447,906	-1.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BJ BORMANN	DIRECTOR	1.00	Director	$0	$0	$0
ANTHONY ATALA	DIRECTOR	1.00	Director	$0	$0	$0
PAOLA ALVAREZ-MALO	DIRECTOR	1.00	Director	$0	$0	$0
OWEN AURELIO	DIRECTOR	1.00	Director	$0	$0	$0
BOB ANACONE	DIRECTOR	1.00	Director	$0	$0	$0
LINDA CRAIB	DIRECTOR	1.00	Director	$0	$0	$0
JONATHAN FLEMING	DIRECTOR	1.00	Director	$0	$0	$0
KATHERINE BARRY	DIRECTOR	1.00	Director	$0	$0	$0
STEPHEN BEHM	DIRECTOR	1.00	Director	$0	$0	$0
PATRICIA BONDURANT	DIRECTOR	1.00	Director	$0	$0	$0
STEPHEN EVANGELISTA	CEO, PRESIDENT	40.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2018	$142,791	$150,783	$12,606	$-7,992

INSTITUTE FOR PEDIATRIC INNOVATION INC C/O STEPHEN EVANGELISTA